- Published at
- by raskmedia.com.au
positive
positive
How to value GMG and CSL shares
The Goodman Group (ASX:GMG) share price and CSL Ltd (ASX:CSL) share price are in focus in 2025. Here's how you could put a value on them.
News for CSL Limited (CSL.AX)
- Published at
- by raskmedia.com.au
positivepositiveAre CSL Ltd (ASX:CSL) shares worth investing in?
Want to value the CSL Ltd (ASX:CSL) share price? Here are 6 key metrics you need to consider.- Published at
- by gurufocus.com
positivepositiveEsperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia
”“ Esperion to Receive an Upfront Payment and Near-Term Milestones Along with a Profitable Transfer Price on Product Sales ”“ ANN ARBOR, Mich., March 03, 2- Published at
- by raskmedia.com.au
positivepositiveCSL share price: why investors are taking notice
Is the CSL Ltd (ASX:CSL) share price cheap? Here are 3 reasons you might want to consider CSL shares.- Published at
- by raskmedia.com.au
positivepositiveHow to value FMG and CSL shares
The Fortescue Ltd (ASX:FMG) share price and CSL Ltd (ASX:CSL) share price are in focus in 2025. Here's how you could put a value on them.- Published at
- by themarketherald.com.au
mixedmixedThis week’s Hot Stock tip is perfect way to pounce on RBA cut – but have an exit plan too
This week’s HotCopper Hot Stock from Wealth Within analysts Fil Tortevski and Pedro Banales…- Published at
- by michaelwest.com.au
neutralneutralMeat and vaccine exports at risk if Trump targets GST
Meat and pharmaceutical exporters will be hit hardest if Donald Trump follows through with threats to levy “reciprocal” tariffs on countries that charge taxes on American products, putting Australia and its GST at risk of retribution. The US president said his new tariffs, flagged shortly after signing off on 25 per cent tariffs on steel […]- Published at
- by gurufocus.com
mixedmixedEuropean Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine
PR NewswireWALTHAM, Mass. and SAN DIEGO, Feb. 14, 2025 - KOSTAIVE represents a significant advancement in vaccine technology, demonstrating superior immuno- Published at
- by gurufocus.com
mixedmixedEuropean Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine
Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today announced that the European Commission- Published at
- by raskmedia.com.au
positivepositiveAre CSL Ltd (ASX:CSL) shares worth investing in?
Want to value the CSL Ltd (ASX:CSL) share price? Here are 6 key metrics you need to consider.- Published at
- by gurufocus.com
positivepositiveEuropean Commission Approves CSL's ANDEMBRY® (garadacimab) for the Prevention of Recurrent Attacks of Hereditary Angioedema (HAE)
PR NewswireMARBURG, Germany, Feb. 13, 2025 - ANDEMBRY®, the first and only once-monthly treatment targeting factor XIIa to prevent attacks in HAE patients- Published at
- by raskmedia.com.au
positivepositiveAre CSL shares or FLT shares better value in 2025?
The CSL Ltd (ASX:CSL) share price and Flight Centre Travel Group Ltd (ASX:FLT) share price are in focus in 2025. Here's how you could put a value on them.- Published at
- by forbes.com
neutralneutralInside Takeda’s Plasma-Derived Therapy Ecosystem
Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, a key revenue driver at $5.85B in 2023.- Published at
- by under30ceo.com
positivepositiveBuffett backs CSL, Life360, WiseTech in latest move
Billionaire investor Warren Buffett's firm invests in Australian companies CSL, Life360, and WiseTech in a strategic financial move.- Published at
- by seekingalpha.com
neutralneutralCSL Limited 2025 Q2 - Results - Earnings Call Presentation (OTCMKTS:CSLLY)
The following slide deck was published by CSL Limited in conjunction with their 2025 Q2 earnings call.- Published at
- by seekingalpha.com
positivepositiveCSL Limited (CSLLY) Q2 2025 Earnings Call Transcript
CSL Limited (OTCQX:CSLLY) Q2 2025 Results Earnings Conference Call February 10, 2025 7:00 PM ETCompany ParticipantsChris Cooper - Vice President and Head of...- Published at
- by abc.net.au
positivepositiveCompanies preparing for US tariffs and strong results in retail
Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.- Published at
- by themarketherald.com.au
mixedmixedASX Market Close: Bourse trades flat as Trumps flags possible tariff exemptions | February 11, 2025
The ASX200 closed flat at 8,484 points. The Aussie bourse pared early…- Published at
- by themarketherald.com.au
positivepositiveCSL up 6% on strong demand for CSL Behring business
CSL Ltd has reported rises in profit and revenue for the first half of the 2025 fiscal year, with particular growth in its CSL Behring arm- Published at
- by themarketherald.com.au
neutralneutralASX Market Open: Traders decide now-looming US steel, aluminium tariffs not quite so scary | Feb 11, 2025
The local bourse is headed for a green open, with the ASX…